Influence of Trabeculectomy and Phaco-trabeculectomy on Corneal Astigmatism

NCT ID: NCT02945202

Last Updated: 2016-10-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2018-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates the effects of trabeculectomy and combined phacoemulsification plus trabeculectomy on corneal astigmatism.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospectively, consecutive patients at the University Hospital of Zurich undergoing either trabeculectomy (trab) or phaco-trabeculectomy (phaco-trab) are included in this study between January and December 2017. The study interventions takes place 6 months after surgery and include examination of refraction, biometry and corneal topography in order to assess the patient's astigmatism. The values are compared to the preoperative baseline values, which are available from patient records.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Astigmatism Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All Eyes

All eyes undergo the same interventions. These are the following examinations: Biometry, Refraction and Corneal Topography. The examinations take place 6 months after surgery

Group Type OTHER

Biometry

Intervention Type DEVICE

All patients undergo all three examinations (biometry, refraction and corneal topography) 6 months after surgery

Refraction

Intervention Type DEVICE

All patients undergo all three examinations (biometry, refraction and corneal topography) 6 months after surgery

Corneal Topography

Intervention Type DEVICE

All patients undergo all three examinations (biometry, refraction and corneal topography) 6 months after surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biometry

All patients undergo all three examinations (biometry, refraction and corneal topography) 6 months after surgery

Intervention Type DEVICE

Refraction

All patients undergo all three examinations (biometry, refraction and corneal topography) 6 months after surgery

Intervention Type DEVICE

Corneal Topography

All patients undergo all three examinations (biometry, refraction and corneal topography) 6 months after surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Trabeculectomy or Phaco-Trabeculectomy between 01/2017 and 12/2017
* Age ≥18 years

Exclusion Criteria

* Acute or chronic corneal diseases
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Astigmatismus2017

Identifier Type: -

Identifier Source: org_study_id